Why the study?
Does adding CRP levels to prognostic scales improve 30-day mortality prediction in patients with community-acquired pneumonia?
Does adding CRP levels to prognostic scales improve 30-day mortality prediction in patients with community-acquired pneumonia?
Adding CRP to standard prognostic scales improves 30-day mortality prediction in patients with community-acquired pneumonia.
May enhance pneumonia risk stratification; hypothesis-generating and should not yet change practice pending prospective validation.
Adding CRP levels to PSI, CURB65 and CRB65 scales improves the 30-day mortality prediction. The highest predictive value is reached with a combination of two scales and CRP. Further validation of that improvement is needed.
No takes yet. Share an insight, caveat, or question.
Menéndez et al. (2009) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: